Cash Flow Rossari Biotech Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
177.00
144.00
136.00
106.00
88.00
63.00
Adjustment
76.00
82.00
55.00
20.00
19.00
16.00
Changes In working Capital
-156.00
-27.00
-112.00
-48.00
-31.00
11.00
Cash Flow after changes in Working Capital
97.00
199.00
79.00
79.00
76.00
91.00
Cash Flow from Operating Activities
43.00
151.00
29.00
47.00
56.00
71.00
Cash Flow from Investing Activities
-103.00
-180.00
-298.00
-37.00
-190.00
-36.00
Cash Flow from Financing Activities
16.00
60.00
291.00
-24.00
156.00
-29.00
Net Cash Inflow / Outflow
-44.00
31.00
22.00
-14.00
23.00
5.00
Opening Cash & Cash Equivalents
69.00
37.00
15.00
29.00
5.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
25.00
69.00
37.00
15.00
29.00
5.00
Compare Cash Flow Results of Rossari Biotech
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
177.62
1101.72
-924.00
-83.88%
Adjustment
76.36
114.77
-38.00
-33.47%
Changes In working Capital
-156.85
-71.98
-85.00
-117.91%
Cash Flow after changes in Working Capital
97.13
1144.51
-1,047.00
-91.51%
Cash Flow from Operating Activities
43.26
878.06
-835.00
-95.07%
Cash Flow from Investing Activities
-103.47
-721.26
618.00
85.65%
Cash Flow from Financing Activities
16.19
43.53
-27.00
-62.81%
Net Cash Inflow / Outflow
-44.03
200.33
-244.00
-121.98%
Opening Cash & Cash Equivalents
69.2
37.64
32.00
83.85%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
25.17
237.97
-212.00
-89.42%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -71.46% vs 416.21% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
43.26
151.56
-71.46%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
